BrainsWay (BWAY) Competitors

SI-BONE (NASDAQ:SIBN) and BrainsWay (NASDAQ:BWAY) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings.

Does the MarketBeat Community favor SIBN or BWAY?

SI-BONE received 104 more outperform votes than BrainsWay when rated by MarketBeat users. Likewise, 69.17% of users gave SI-BONE an outperform vote while only 67.62% of users gave BrainsWay an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 175 69.17%	Underperform Votes 78 30.83%
BrainsWay	Outperform Votes 71 67.62%	Underperform Votes 34 32.38%

Which has higher earnings & valuation, SIBN or BWAY?

BrainsWay has lower revenue, but higher earnings than SI-BONE. SI-BONE is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$176.60M	4.54	-$43.34M	-$0.64	-29.39
BrainsWay	$43.46M	5.10	-$4.20M	$0.20	58.65

Do analysts prefer SIBN or BWAY?

SI-BONE currently has a consensus price target of $22.50, suggesting a potential upside of 19.62%. BrainsWay has a consensus price target of $14.25, suggesting a potential upside of 21.48%. Given BrainsWay's higher probable upside, analysts clearly believe BrainsWay is more favorable than SI-BONE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
BrainsWay	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer SIBN or BWAY?

In the previous week, SI-BONE had 5 more articles in the media than BrainsWay. MarketBeat recorded 10 mentions for SI-BONE and 5 mentions for BrainsWay. SI-BONE's average media sentiment score of 1.28 beat BrainsWay's score of 0.64 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrainsWay	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals believe in SIBN or BWAY?

98.1% of SI-BONE shares are owned by institutional investors. Comparatively, 30.1% of BrainsWay shares are owned by institutional investors. 4.0% of SI-BONE shares are owned by insiders. Comparatively, 19.0% of BrainsWay shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more risk and volatility, SIBN or BWAY?

SI-BONE has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, BrainsWay has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

Is SIBN or BWAY more profitable?

BrainsWay has a net margin of 3.88% compared to SI-BONE's net margin of -23.82%. BrainsWay's return on equity of 3.52% beat SI-BONE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-23.82%	-22.51%	-16.53%
BrainsWay	3.88%	3.52%	2.26%

Summary

BrainsWay beats SI-BONE on 10 of the 17 factors compared between the two stocks.